ATP6V1E1-C22ORF45 Fusion FISH Probe
The ATP6V1E1-C22ORF45 Fusion FISH Probe is used to confirm a fusion of the ATP6V1E1 and C22ORF45 genes. The fusion of the ATP6V1E1 and C22ORF45 genes has been associated with Pancreatic Adenocarcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| ATP6V1E1-C22ORF45-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| ATP6V1E1-C22ORF45-20-RERE | 20 (40 μL) | 200 μL |
|
|
| ATP6V1E1-C22ORF45-20-REOR | 20 (40 μL) | 200 μL |
|
|
| ATP6V1E1-C22ORF45-20-REGO | 20 (40 μL) | 200 μL |
|
|
| ATP6V1E1-C22ORF45-20-REGR | 20 (40 μL) | 200 μL |
|
|
| ATP6V1E1-C22ORF45-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| ATP6V1E1-C22ORF45-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| ATP6V1E1-C22ORF45-20-OROR | 20 (40 μL) | 200 μL |
|
|
| ATP6V1E1-C22ORF45-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| ATP6V1E1-C22ORF45-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| ATP6V1E1-C22ORF45-20-GORE | 20 (40 μL) | 200 μL |
|
|
| ATP6V1E1-C22ORF45-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| ATP6V1E1-C22ORF45-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| ATP6V1E1-C22ORF45-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| ATP6V1E1-C22ORF45-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| ATP6V1E1-C22ORF45-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| ATP6V1E1-C22ORF45-20-GROR | 20 (40 μL) | 200 μL |
|
|
| ATP6V1E1-C22ORF45-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| ATP6V1E1-C22ORF45-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| ATP6V1E1-C22ORF45-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| ATP6V1E1-C22ORF45-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| ATP6V1E1-C22ORF45-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| ATP6V1E1-C22ORF45-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| ATP6V1E1-C22ORF45-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| ATP6V1E1-C22ORF45-20-AQAQ | 20 (40 μL) | 200 μL |
|
ATP6V1E1 Gene Summary
This gene encodes a component of vacuolar ATPase (V-ATPase), a multisubunit enzyme that mediates acidification of eukaryotic intracellular organelles. V-ATPase dependent organelle acidification is necessary for such intracellular processes as protein sorting, zymogen activation, receptor-mediated endocytosis, and synaptic vesicle proton gradient generation. V-ATPase is composed of a cytosolic V1 domain and a transmembrane V0 domain. The V1 domain consists of three A, three B, and two G subunits, as well as a C, D, E, F, and H subunit. The V1 domain contains the ATP catalytic site. This gene encodes alternate transcriptional splice variants, encoding different V1 domain E subunit isoforms. Pseudogenes for this gene have been found in the genome. [provided by RefSeq, Jul 2008]
Gene Name: ATPase H+ Transporting V1 Subunit E1
Chromosome: CHR22: 18074902 -18111588
Locus: 22q11.21
Gene Diseases
The ATP6V1E1 C22ORF45 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Pancreatic Adenocarcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|